SCHEMBL49460

SCHEMBL49460

O=C(Oc1cc(O)cc2c1C[C@H](O)[C@@H](c1ccc(O)c(O)c1)O2)c1cc(O)c(O)c(O)c1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYNJ2 O15056 3/20 0.76
BACE1 P56817 6/20 0.63
KDM4E B2RXH2 5/20 0.63
PKM P14618 4/20 0.63
SNCA P37840 3/20 0.63
MEN1 O00255 3/20 0.63
MAPT P10636 3/20 0.63
RECQL P46063 3/20 0.63
KMT2A Q03164 3/20 0.63
HSD17B10 Q99714 3/20 0.63
DYRK1A Q13627 3/20 0.63
BCL2 P10415 2/20 0.63
PSMB5 P28074 2/20 0.63
PGD P52209 2/20 0.63
APP P05067 2/20 0.63
RAD52 P43351 2/20 0.63
CYP3A4 P08684 2/20 0.63
ALOX15 P16050 2/20 0.63
TDP1 Q9NUW8 2/20 0.63
ADAMTS4 O75173 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cianidanol SCHEMBL28452121 0.88 SYNJ2 (0.80) SYNJ2BACE1KDM4EPKMSNCA
SCHEMBL2464467 0.88 DYRK1A (0.81) SYNJ2BACE1KDM4EPKMSNCA
SCHEMBL17430773 0.88 DYRK1A (0.81) SYNJ2BACE1KDM4EPKMSNCA
SCHEMBL17107164 0.88 DYRK1A (0.81) SYNJ2BACE1KDM4EPKMSNCA
SCHEMBL18393487 0.88 SYNJ2 (0.73) SYNJ2BACE1KDM4EPKMSNCA
Cianidanol SCHEMBL28937698 0.87 SYNJ2 (0.78) SYNJ2BACE1KDM4EPKMSNCA
SCHEMBL15773519 0.87 SYNJ2 (1.00) SYNJ2BACE1KDM4EPKMSNCA
(-)-Epicatechin SCHEMBL27800385 0.87 SYNJ2 (0.78) SYNJ2BACE1KDM4EPKMSNCA
Cianidanol SCHEMBL21611697 0.87 SYNJ2 (0.78) SYNJ2BACE1KDM4EPKMSNCA
(-)-Epicatechin SCHEMBL29137174 0.87 SYNJ2 (0.78) SYNJ2BACE1KDM4EPKMSNCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4692 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122031766-A Cu2+Chelating EGCG nanoparticle functionalized composite bone repair hydrogel material and preparation method thereof 青岛大学附属医院 2026-05-15 CN claimed
US-20260130895-A1 METABOLISM ENHANCING COMPOSITIONS Red Mountain Med Spa, LLC (US) 2026-05-14 US claimed
EP-4739275-A1 VITELLARIA PARADOXA EXTRACT COMPOSITION Bunge Loders Croklaan B.V. (NL) 2026-05-13 EP claimed
EP-3682865-B1 USE OF A GREEN TEA EXTRACT WHICH HAS MODIFIED AMOUNTS OF INGREDIENTS FOR SKIN-WHITENING OR PREVENTING OR IMPROVING SKIN WRINKLES AMOREPACIFIC CORP (KR) 2026-04-29 EP claimed
EP-4719376-A2 ANTIPERSPIRANT COMPOSITIONS Elementis Specialties, Inc. (US) 2026-04-08 EP claimed
EP-4701427-A1 THERMAL ENERGY SYSTEM FOR ADMINISTERING ACTIVE AGENTS UltraOral Ltd. (IL) 2026-03-04 EP claimed
EP-4606388-A9 METAL-POLYPHENOL COMPLEX PARTICLE, DRUG-LIPID PARTICLE, METHOD FOR PREPARING SAME, AND USE THEREOF Hunan Lonstar Biotech Co., Ltd. (CN) 2026-02-25 EP claimed
US-20260048142-A1 METAL-CHELATED POLYPHENOL COMPLEX NANOPARTICLE, DRUG-LIPID PARTICLE, PREPARATION METHODS FOR THE SAME, AND USES THEREOF HUNAN LONSTAR BIOTECH CO LTD (CN) 2026-02-19 US claimed
US-12551470-B2 Metabolism enhancing compositions Red Mountain Med Spa, LLC (US) 2026-02-17 US claimed
EP-4664553-A1 NEGATIVE ELECTRODE ACTIVE MATERIAL, NEGATIVE ELECTRODE SLURRY, NEGATIVE ELECTRODE, AND SECONDARY BATTERY LG Energy Solution, Ltd. (KR) 2025-12-17 EP claimed
US-20020034576-A1 Carbonated beverage for strengthening acid resistancy of teeth (with the taste of cream soda) BURGESS JAMES MICHEAL (US) 2002-03-21 US claimed
WO-2002002096-A2 ORAL COMPOSITIONS COMPRISING HOST-RESPONSE MODULATING AGENT THE PROCTER & GAMBLE COMPANY (US) 2002-01-10 WO claimed
EP-1159007-A1 USE OF GALLIC ACID ESTERS TO INCREASE BIOAVAILABILITY OF ORALLY ADMINISTERED PHARMACEUTICAL COMPOUNDS Avmax, Inc. (US) 2001-12-05 EP claimed
WO-2001080870-A2 COMPOSITIONS DERIVED FROM CRANBERRY AND GRAPEFRUIT AND THERAPEUTIC USES THEREFOR OCEAN SPRAY CRANBERRIES, INC. (US) 2001-11-01 WO claimed
WO-2001049307-A1 CATECHINS AND GREEN TEA EXTRACT FOR THE TREATMENT OF AMYLOIDOSIS IN ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES PROTEOTECH, INC. (US) 2001-07-12 WO claimed
WO-2000074662-A2 ARTHRITIS TREATMENT UNIVERSITY OF SHEFFIELD (GB) 2000-12-14 WO claimed
WO-2000051643-A1 USE OF GALLIC ACID ESTERS TO INCREASE BIOAVAILABILITY OF ORALLY ADMINISTERED PHARMACEUTICAL COMPOUNDS AVMAX, INC. (US) 2000-09-08 WO claimed
US-5788971-A PLANT EXTRACT SKY. FOOD CO., LTD. (JP) 1998-08-04 US claimed
US-5750563-A MIXING A CATECHIN, A FLAVONE, OR A TANNIN INTO EMULSIFIED MIXTURE OF KOJIC ACID, NONIONIC SURFACTANT, AND ULTRAVIOLET LIGHT ABSORBER; STABILIZATION, DISCOLORATION INHIBITION SANSHO SEIYAKU CO., LTD. (JP) 1998-05-12 US claimed
US-5204089-A Using a tea leaf polyphenol e.g., acatchin gallate, theaflavin or a theaflavin gallate; streptococcus glucosyltransferase inhibitor MITSUI NORIN CO., LTD. (JP) 1993-04-20 US claimed